CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,033,000 | +108.3% | 20,000 | 0.0% | 0.73% | +101.4% |
| Q2 2022 | $496,000 | -1.0% | 20,000 | 0.0% | 0.36% | 0.0% |
| Q1 2022 | $501,000 | -31.2% | 20,000 | 0.0% | 0.36% | -23.0% |
| Q4 2021 | $728,000 | +70.1% | 20,000 | -20.0% | 0.47% | +61.2% |
| Q3 2021 | $428,000 | +6.5% | 25,000 | -16.7% | 0.29% | +21.2% |
| Q2 2021 | $402,000 | -73.8% | 30,000 | 0.0% | 0.24% | -73.7% |
| Q1 2021 | $1,537,000 | -17.3% | 30,000 | 0.0% | 0.91% | -14.8% |
| Q4 2020 | $1,858,000 | -43.5% | 30,000 | -50.0% | 1.07% | -2.6% |
| Q3 2020 | $3,288,000 | +90.5% | 60,000 | +100.0% | 1.10% | +5.3% |
| Q2 2020 | $1,726,000 | +43.2% | 30,000 | 0.0% | 1.04% | -2.4% |
| Q1 2020 | $1,205,000 | +21.8% | 30,000 | +20.0% | 1.07% | +48.7% |
| Q4 2019 | $989,000 | – | 25,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |